×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
合肥物质科学研究院 [5]
中南大学 [3]
兰州大学 [1]
中国医学科学院 北京... [1]
内容类型
期刊论文 [10]
发表日期
2022 [3]
2021 [1]
2019 [2]
2018 [1]
2016 [1]
2013 [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共10条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
提交时间升序
提交时间降序
题名升序
题名降序
作者升序
作者降序
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor
期刊论文
THORACIC CANCER, 2022
作者:
Wang, Wenxian
;
Wang, Qian
;
Xu, Chunwei
;
Li, Ziming
;
Song, Zhengbo
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2022/12/23
checkpoint inhibitor pneumonitis
Chinese experts consensus
immune checkpoint inhibitor-related adverse effects
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China
期刊论文
THORACIC CANCER, 2022
作者:
Xu, Chunwei
;
Si, Lu
;
Wang, Wenxian
;
Li, Ziming
;
Song, Zhengbo
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2022/12/22
fusion
precision medicine
solid tumor
targeted therapy
tyrosine receptor kinase
Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective study
期刊论文
GENES CHROMOSOMES & CANCER, 2022
作者:
Wang, Wenxian
;
Gu, Xiaodong
;
Si, Jinfei
;
Pu, Xingxiang
;
Wang, Liping
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2022/05/16
BRAF mutation
immune checkpoint inhibitors
non-small cell lung cancer
PD-L1
targeted therapy
The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study
期刊论文
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021
作者:
Wang, Wenxian
;
Gu, Xiaodong
;
Wang, Liping
;
Pu, Xingxiang
;
Feng, Huijing
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2022/01/10
Non-small cell lung cancer
PD-L1
Immune checkpoint inhibitor
Immune-related adverse event
Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients
期刊论文
2019, 卷号: 16, 期号: 3, 页码: 556-564
作者:
Hu Xingsheng
;
Yang Dongyong
;
Li Yalun
;
Li Li
;
Wang Yan
收藏
  |  
浏览/下载:52/0
  |  
提交时间:2020/01/03
BRCA1
BRCA2
Germline BRCA mutations
non-small cell lung cancer
prevalence
Prevalence and clinical significance of pathogenic germline BRCA1 2 mutations in Chinese non-small cell lung cancer patients
期刊论文
Cancer Biology & Medicine, 2019, 卷号: 16
作者:
Hu Xingsheng
;
Yang Dongyong
;
Li Yalun
;
Li Li
;
Wang Yan
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2020/12/28
SUSCEPTIBILITY LOCUS
PROSTATE-CANCER
OVARIAN-CANCER
BREAST
RISK
MULTICENTER
EXPRESSION
INHIBITORS
VARIANTS
CARRIERS
Germline BRCA mutations
non-small cell lung cancer
prevalence
BRCA1
BRCA2
miR-221 inhibits autophagy and targets TP53INP1 in colorectal cancer cells.
期刊论文
Experimental and Therapeutic Medicine, 2018, 卷号: 15, 期号: 2, 页码: 1712-1717
作者:
Liao, Dan
;
Li, Tong
;
Ye, Caiguo
;
Zeng, Liuyan
;
Li, Huahui
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2019/12/03
autophagy
colorectal cancer
miR-221
tumor protein 53-induced nuclear protein 1
miR-96 induces cisplatin chemoresistance in non-small cell lung cancer cells by downregulating SAMD9
期刊论文
Oncology letters, 2016, 卷号: 11, 期号: 2, 页码: 945-952
作者:
Wu, Lin*
;
Pu, Xingxiang
;
Wang, Qianzhi
;
Cao, Jun
;
Xu, Fang
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/03
SAMD9
apoptosis
chemoresistance
cisplatin
miR-96
non-small cell lung cancer
Comparison of KRAS/BRAF mutations between primary tumors and serum in colorectal cancer: Biological and clinical implications
期刊论文
Oncology Letters, 2013, 卷号: 5, 期号: 1, 页码: 249-254
作者:
Pu, Xingxiang
;
Pan, Zhizhong
;
Huang, Ying
;
Tan, Ying
;
Guo, Hongqiang
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/03
colorectal cancer
cetuximab
KRAS
BRAF
serum
甘肃省糜子生态气候研究及适生种植区划
期刊论文
干旱气象, 2004, 期号: 2, 页码: 52-56
作者:
姚小英
;
邓振镛
;
蒲金涌
;
姚晓红
;
马兴祥
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2016/07/18
糜子
生态气候
适生种植区划
©版权所有 ©2017 CSpace - Powered by
CSpace